Skip to main content
Top
Published in: BMC Dermatology 1/2013

Open Access 01-12-2013 | Research article

Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study

Authors: Javaria Mona Khalid, Gary Globe, Kathleen M Fox, Dina Chau, Andrew Maguire, Chio-Fang Chiou

Published in: BMC Dermatology | Issue 1/2013

Login to get access

Abstract

Background

In the UK, referrals to specialists are initiated by general practitioners (GPs). Study objectives were to estimate the incidence of diagnosed psoriasis in the UK and identify factors associated with GP referrals to dermatologists.

Methods

Newly diagnosed patients with psoriasis were identified in The Health Improvement Network (THIN) database between 01 July 2007-31 Oct 2009. Incidence of diagnosed psoriasis was calculated using the number of new psoriasis patients in 2008 and the mid-year total patient count for THIN in 2008. A nested case–control design and conditional logistic regression were used to identify factors associated with referral.

Results

Incidence rate of diagnosed adult psoriasis in 2008 was 28/10,000 person-years. Referral rate to dermatologists was 18.1 (17.3-18.9) per 100 person-years. In the referred cohort (N=1,950), 61% were referred within 30 days of diagnosis and their median time to referral was 0 days from diagnosis. For those referred after 30 days (39%, median time to referral: 5.6 months), an increase in the number of GP visits prior to referral increased the likelihood of referral (OR=1.87 95% CI:1.73-2.01). A prescription of topical agents such as vitamin D3 analogues 30 days before referral increased the likelihood of being referred (OR=4.67 95% CI: 2.78-7.84), as did corticosteroids (OR=2.45 95% CI: 1.45-4.07) and tar products (OR=1.95 95% CI: 1.02-3.75).

Conclusions

Estimates of the incidence of diagnosed adult psoriasis, referral rates to dermatologists, and characteristics of referred patients may assist in understanding the burden on the UK healthcare system and managing this population in primary and secondary care.
Appendix
Available only for authorised users
Literature
1.
go back to reference Greaves MW, Weinstein GD: Treatment of psoriasis. N Engl J Med 1995, 332: 581–588. 10.1056/NEJM199503023320907CrossRefPubMed Greaves MW, Weinstein GD: Treatment of psoriasis. N Engl J Med 1995, 332: 581–588. 10.1056/NEJM199503023320907CrossRefPubMed
2.
go back to reference Conway P, Currie CJ: Descriptive epidemiology of hospitalisation for psoriasis. Curr Med Res Opin 2008, 24: 3487–3491. 10.1185/03007990802583563CrossRefPubMed Conway P, Currie CJ: Descriptive epidemiology of hospitalisation for psoriasis. Curr Med Res Opin 2008, 24: 3487–3491. 10.1185/03007990802583563CrossRefPubMed
3.
go back to reference Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ: Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005, 141: 1537–1541. 10.1001/archderm.141.12.1537CrossRefPubMed Gelfand JM, Weinstein R, Porter SB, Neimann AL, Berlin JA, Margolis DJ: Prevalence and treatment of psoriasis in the United Kingdom: a population-based study. Arch Dermatol 2005, 141: 1537–1541. 10.1001/archderm.141.12.1537CrossRefPubMed
4.
go back to reference Gelfand JM, Troxel AB, Lewis JD, et al.: The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007, 143: 1493–1499. 10.1001/archderm.143.12.1493PubMed Gelfand JM, Troxel AB, Lewis JD, et al.: The risk of mortality in patients with psoriasis: results from a population-based study. Arch Dermatol 2007, 143: 1493–1499. 10.1001/archderm.143.12.1493PubMed
5.
go back to reference Horn EJ, Fox KM, Patel V, et al.: Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol 2007, 57: 963–971. 10.1016/j.jaad.2007.07.023CrossRefPubMed Horn EJ, Fox KM, Patel V, et al.: Association of patient-reported psoriasis severity with income and employment. J Am Acad Dermatol 2007, 57: 963–971. 10.1016/j.jaad.2007.07.023CrossRefPubMed
6.
go back to reference Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM: Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999, 41: 401–407. 10.1016/S0190-9622(99)70112-XCrossRefPubMed Rapp SR, Feldman SR, Exum ML, Fleischer AB Jr, Reboussin DM: Psoriasis causes as much disability as other major medical diseases. J Am Acad Dermatol 1999, 41: 401–407. 10.1016/S0190-9622(99)70112-XCrossRefPubMed
7.
go back to reference Duque MI, Yosipovitch G, Chan YH, Smith R, Levy P: Itch, pain, and burning sensation are common symptoms in mild to moderate chronic venous insufficiency with an impact on quality of life. J Am Acad Dermatol 2005, 53: 504–508.CrossRefPubMed Duque MI, Yosipovitch G, Chan YH, Smith R, Levy P: Itch, pain, and burning sensation are common symptoms in mild to moderate chronic venous insufficiency with an impact on quality of life. J Am Acad Dermatol 2005, 53: 504–508.CrossRefPubMed
8.
go back to reference Husted JA, Tom BD, Schentag CT, Farewell VT, Gladman DD: Occurrence and correlates of fatigue in psoriatic arthritis. Ann Rheum Dis 2009, 68: 1553–1558. 10.1136/ard.2008.098202CrossRefPubMed Husted JA, Tom BD, Schentag CT, Farewell VT, Gladman DD: Occurrence and correlates of fatigue in psoriatic arthritis. Ann Rheum Dis 2009, 68: 1553–1558. 10.1136/ard.2008.098202CrossRefPubMed
9.
go back to reference Chan B, Hales B, Shear N, et al.: Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasis. J Cutan Med Surg 2009, 13: 192–197.CrossRefPubMed Chan B, Hales B, Shear N, et al.: Work-related lost productivity and its economic impact on Canadian patients with moderate to severe psoriasis. J Cutan Med Surg 2009, 13: 192–197.CrossRefPubMed
11.
go back to reference Smith CH, Anstey AV, Barker JN, et al.: British association of dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 2009, 161: 987–1019. 10.1111/j.1365-2133.2009.09505.xCrossRefPubMed Smith CH, Anstey AV, Barker JN, et al.: British association of dermatologists' guidelines for biologic interventions for psoriasis 2009. Br J Dermatol 2009, 161: 987–1019. 10.1111/j.1365-2133.2009.09505.xCrossRefPubMed
13.
go back to reference Huerta C, Rivero E, Rodriguez LA: Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007, 143: 1559–1565. 10.1001/archderm.143.12.1559CrossRefPubMed Huerta C, Rivero E, Rodriguez LA: Incidence and risk factors for psoriasis in the general population. Arch Dermatol 2007, 143: 1559–1565. 10.1001/archderm.143.12.1559CrossRefPubMed
15.
go back to reference Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL: Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007, 16: 393–401. 10.1002/pds.1335CrossRefPubMed Lewis JD, Schinnar R, Bilker WB, Wang X, Strom BL: Validation studies of the health improvement network (THIN) database for pharmacoepidemiology research. Pharmacoepidemiol Drug Saf 2007, 16: 393–401. 10.1002/pds.1335CrossRefPubMed
16.
go back to reference Chisholm J: The Read clinical classification. Br Med J 1990, 300: 1467. Chisholm J: The Read clinical classification. Br Med J 1990, 300: 1467.
17.
go back to reference Maguire A, Blak BT, Thompson M: The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf 2009, 18: 76–83. 10.1002/pds.1688CrossRefPubMed Maguire A, Blak BT, Thompson M: The importance of defining periods of complete mortality reporting for research using automated data from primary care. Pharmacoepidemiol Drug Saf 2009, 18: 76–83. 10.1002/pds.1688CrossRefPubMed
18.
go back to reference Seminara NM, Abuabara K, Shin DB, et al.: Validity of the health improvement network (THIN) for the study of psoriasis. Br J Dermatol 2011, 164: 602–609.PubMedPubMedCentral Seminara NM, Abuabara K, Shin DB, et al.: Validity of the health improvement network (THIN) for the study of psoriasis. Br J Dermatol 2011, 164: 602–609.PubMedPubMedCentral
20.
go back to reference Edwards P, Robert I: Population adiposity and climate change. Int J Epidemiol 2009, 38: 1137–1140. 10.1093/ije/dyp172CrossRefPubMed Edwards P, Robert I: Population adiposity and climate change. Int J Epidemiol 2009, 38: 1137–1140. 10.1093/ije/dyp172CrossRefPubMed
21.
go back to reference Gillard SE, Finlay AY: Current management of psoriasis in the United Kingdom: patterns of prescribing and resource use in primary care. Int J Clin Pract 2005, 59: 1260–1267. 10.1111/j.1368-5031.2005.00680.xCrossRefPubMed Gillard SE, Finlay AY: Current management of psoriasis in the United Kingdom: patterns of prescribing and resource use in primary care. Int J Clin Pract 2005, 59: 1260–1267. 10.1111/j.1368-5031.2005.00680.xCrossRefPubMed
24.
go back to reference Langan SM, Seminara NM, Shin DB, et al.: Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 2011. 10.1038/jid.2011.365 Langan SM, Seminara NM, Shin DB, et al.: Prevalence of metabolic syndrome in patients with psoriasis: a population-based study in the United Kingdom. J Invest Dermatol 2011. 10.1038/jid.2011.365
25.
go back to reference Griffiths CE, Clark CM, Chalmers RJ, Li Wan Po A, Williams HC: A systematic review of treatments for severe psoriasis. Health Technol Assess 2000,4(1):1–25.PubMed Griffiths CE, Clark CM, Chalmers RJ, Li Wan Po A, Williams HC: A systematic review of treatments for severe psoriasis. Health Technol Assess 2000,4(1):1–25.PubMed
Metadata
Title
Treatment and referral patterns for psoriasis in United Kingdom primary care: a retrospective cohort study
Authors
Javaria Mona Khalid
Gary Globe
Kathleen M Fox
Dina Chau
Andrew Maguire
Chio-Fang Chiou
Publication date
01-12-2013
Publisher
BioMed Central
Published in
BMC Dermatology / Issue 1/2013
Electronic ISSN: 1471-5945
DOI
https://doi.org/10.1186/1471-5945-13-9

Other articles of this Issue 1/2013

BMC Dermatology 1/2013 Go to the issue